| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 10/08/2009 | US20090252739 Cerebral Infarction Suppressant |
| 10/08/2009 | US20090252718 Phospholipase(s) and Use(s) Thereof |
| 10/08/2009 | US20090252685 High penetration prodrug compositions of prostaglandins and related compounds |
| 10/08/2009 | CA2757442A1 Use of ribose in first response to acute myocardial infarction |
| 10/08/2009 | CA2720343A1 Heterocyclic derivative and use thereof |
| 10/08/2009 | CA2720280A1 Compositions and method for reducing scar formation in wound healing |
| 10/08/2009 | CA2720278A1 Agent for preventing and/or treating vascular diseases |
| 10/08/2009 | CA2720049A1 Pyrimidine derivative having cell protecting effect and uses thereof |
| 10/08/2009 | CA2720011A1 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 10/08/2009 | CA2719985A1 Tetrahydronaphthyridines and aza derivatives thereof as histamine h3 receptor antagonists |
| 10/08/2009 | CA2719362A1 Pyrrolotriazinone derivatives for use as stearoyl coa desaturase inhibitors |
| 10/07/2009 | EP2107055A1 Diosmetin derivatives, process for their preparation and pharmaceutical compositions containing them |
| 10/07/2009 | EP2107050A1 Lipoxin compounds |
| 10/07/2009 | EP2106791A1 Glutamine or glutamine-containing dipeptide in a specific dosage for the treatment of inflammation |
| 10/07/2009 | EP1617216B1 Novel method of screening |
| 10/07/2009 | EP1505075B1 Antibody to human insulin-like growth factor |
| 10/07/2009 | EP1501493B1 Use of epa and dha in secondary prevention of strokes |
| 10/07/2009 | EP1434791B1 Specific binding agents of human angiopoietin-2 |
| 10/07/2009 | EP1308441B1 2-aminopyridine compounds and use thereof as drugs |
| 10/07/2009 | EP1248774B1 Polyhydroxystilbenes and stilbene oxides as antipsoriatic agents and protein kinase inhibitors |
| 10/07/2009 | EP1180036B1 Cell therapy for chronic stroke |
| 10/07/2009 | EP0861247B1 Novel imidazole n-benzyldioxol derivatives, method for preparing same, resulting intermediates, pharmaceutical compositions and use of said derivatives as endothelin antagonists |
| 10/07/2009 | CN101553491A Quinoxaline derivative |
| 10/07/2009 | CN101553488A Hypertension-ameliorating agent |
| 10/07/2009 | CN101553484A Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 10/07/2009 | CN101553475A Hydroxamates as inhibitors of histone deacetylase |
| 10/07/2009 | CN101553244A Treatment for intimal hyperplasia and related conditions |
| 10/07/2009 | CN101553226A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 10/07/2009 | CN101553219A Urea and sulfamide derivatives as TAFIa inhibitors |
| 10/07/2009 | CN101553137A Apples with high polyphenolic content |
| 10/07/2009 | CN101550162A Fostriecin derivant and medicinal use thereof |
| 10/07/2009 | CN101550131A Alpha crystal form of ketanserin and method for preparing the same |
| 10/07/2009 | CN101550124A Diosmetin compounds, a process for their preparation and pharmaceutical composition containing them |
| 10/07/2009 | CN101550114A Thiazole derivatives having CB1-antagonistic, agonistic or partial agonistic activity |
| 10/07/2009 | CN101550107A Method for preparing telmisartan |
| 10/07/2009 | CN101549187A Device for local and/or regional delivery employing liquid formulations of therapeutic agents |
| 10/07/2009 | CN101549150A Application of prourokinase and prourokinase mutant in acute myocardial infarction facilitated percutaneous coronary artery intervention |
| 10/07/2009 | CN101549148A Application of polypeptide in preparing the medicine promoting the transformation from endocardium cell to interstitial cell |
| 10/07/2009 | CN101549142A Traditional Chinese medicine composition for treating pulmonary heart disease and preparation method thereof |
| 10/07/2009 | CN101549121A Traditional Chinese medicine preparation for curing hear disease |
| 10/07/2009 | CN101549115A Chinese traditional medicine suppository for eliminating hemorrhoid |
| 10/07/2009 | CN101549109A Medicament for treating cerebral atherosclerosis |
| 10/07/2009 | CN101549106A Traditional Chinese medicine with special efficacy for cerebral thrombosis and preparation method thereof |
| 10/07/2009 | CN101549079A Drug for curing cancer by using 6 prescriptions and 56 Chinese herbal medicines |
| 10/07/2009 | CN101549070A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular disease |
| 10/07/2009 | CN101549064A Medicament composition containing chilopod acting on NEI network and uses thereof |
| 10/07/2009 | CN101549057A Chinese medicine composition for curing hyperlipemia, cerebral arteriosclerosis and ischemic apoplexy and method of preparing the same |
| 10/07/2009 | CN101549056A A fat-soluble component extract of rhizoma typhonii for protecting ischemic brain damage |
| 10/07/2009 | CN101549055A Preparation method of Shuxintongmai dropping pills |
| 10/07/2009 | CN101549050A Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 10/07/2009 | CN101549047A Five-element health-preserving capsule |
| 10/07/2009 | CN101549035A Medicament for treating cerebral thrombosis and sequela diseases and preparation method thereof |
| 10/07/2009 | CN101549021A Method for testing quality of perfoliate knotweed medicinal materials |
| 10/07/2009 | CN101549017A Traditional Chinese medicine composition for treating arrhythmia and preparation method thereof |
| 10/07/2009 | CN101549014A Heart-protecting musk oral preparation and preparation method thereof |
| 10/07/2009 | CN101549013A Capsule, tablet and granules of minium and preparation method |
| 10/07/2009 | CN101548997A Application of medicament acting on NEI network for preparing medicine for curing vas pathological changes |
| 10/07/2009 | CN101548995A Application of Viscum album extract as NF-kB inhibitor |
| 10/07/2009 | CN101548985A Compound antihypertensive drug and preparation method thereof |
| 10/07/2009 | CN101548973A Composition containing dihydropyridine calcium channel blocker and preparation method thereof |
| 10/07/2009 | CN101548967A Pharmaceutical composition |
| 10/07/2009 | CN101548966A Application of salvianolic acid A in salvia miltiorrhiza |
| 10/07/2009 | CN101548944A Pharmaceutical composition containing enoximone and preparation method thereof |
| 10/07/2009 | CN101548942A Oral solid pharmaceutical composition containing clinofibrate |
| 10/07/2009 | CN100546977C New compounds for the inhibition of rotamases and use thereof |
| 10/07/2009 | CN100546653C Time selecting released preparation containing angiotensin II 1 receptor antagonist |
| 10/07/2009 | CN100546614C Orally taken traditional Chinese medicine composition for treating heart failure |
| 10/07/2009 | CN100546589C Preparation of caterpillar fungus cephalosporin powder anti-arrhythmia effective part and its medicinal preparation |
| 10/07/2009 | CN100546588C Process for preparing calf blood protein-removed extract injection |
| 10/07/2009 | CN100546585C Compound puerarin injection and preparation method thereof |
| 10/07/2009 | CN100546583C Use of rhizoma anemarrhenae total saponin in preparation of medicine for treating hyperlipemia and arterial sclerosis |
| 10/07/2009 | CN100546580C Nicotin or isonicotin benzothiazole derivatives |
| 10/07/2009 | CN100546575C Medicine composition containing red clover prime and prunetin and its medicinal application |
| 10/06/2009 | US7598396 Contacting carvedilol and ethyl acetate to form a solution, and cooling the solution whereby a precipitate is formed; improves performance characteristics of pharmaceutical product |
| 10/06/2009 | US7598355 Characterization of GRP94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 10/06/2009 | US7598293 Antidiabetic agents, antilipemic agents, dietetics, anticholesterol agents, hypotensive agents, cardiovascular disorders; (S)-Ethyl 2-methoxy-3-[4-{3-(4-methanesulfonyloxyphenyl) propylamino}phenyl]propionate |
| 10/06/2009 | US7598277 cancer, inflammatory, autoimmune, infectious and viral diseases , destructive bone disorders, proliferative and neurodegenerative disorders; 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine |
| 10/06/2009 | US7598260 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 10/06/2009 | US7598253 Reverse-turn mimetics and methods relating thereto |
| 10/06/2009 | US7598242 Compounds for the treatment of inflammatory disorders |
| 10/06/2009 | US7598241 Carboxamide derivatives and their use as factor Xa inhibitors |
| 10/06/2009 | US7598232 Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted-benzylsulfones for treating proliferative disorders |
| 10/06/2009 | US7598228 Administering by direct injection into heart an expression vector comprising a nucleic acid sequence encoding AOP-1 operably linked to a promoter, wherein expression of nucleic acid sequence within cells of heart enhances production of AOP-1, protecting against myocardial cell death |
| 10/06/2009 | US7598056 Factor VII or VIIA-like molecules |
| 10/06/2009 | US7597889 Recombinant polypeptides and nucleic acids; Graft-vs-host disease, host-vs-graft disease, organ transplant rejection, bone-marrow transplant rejection, autoimmune vasculitis, arthritis or asthma |
| 10/06/2009 | US7597875 Diaminedioxime radiometal complexes |
| 10/01/2009 | WO2009120837A2 Leucine-rich peptide compositions and methods for isolation |
| 10/01/2009 | WO2009120815A2 Therapeutic compositions and methods |
| 10/01/2009 | WO2009120762A2 Human cardiovascular progenitor cells |
| 10/01/2009 | WO2009120307A2 Method of treating peripheral arterial disease |
| 10/01/2009 | WO2009120244A1 Image-guided therapy of myocardial disease: composition, manufacturing and applications |
| 10/01/2009 | WO2009120140A1 Novel 5,7-disubstituted [1,3]thiazolo[4,5-d]pyrimidin-2(3h)-one derivatives 258 |
| 10/01/2009 | WO2009120101A1 Herbal alcohol tincture for oral use |
| 10/01/2009 | WO2009120052A1 Pharmaceutical composition having a synergistic effect, for the treatment of high blood pressure and dyslipidemia |
| 10/01/2009 | WO2009119726A1 Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 10/01/2009 | WO2009119692A1 Novel glycolipid and use thereof |
| 10/01/2009 | WO2009119673A1 Transdermally absorbable preparation |
| 10/01/2009 | WO2009119672A1 COMPOSITION FOR STABILIZING β-BLOCKER, AND TRANSDERMALLY ABSORBABLE PREPARATION COMPRISING THE COMPOSITION |
| 10/01/2009 | WO2009119537A1 Hydroxyquinoxalinecarboxamide derivative |
| 10/01/2009 | WO2009119534A1 Novel tetrahydroisoquinoline derivative |